已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Trough Levels and Antibodies to Infliximab May Not Predict Response to Intensification of Infliximab Therapy in Patients With Inflammatory Bowel Disease

英夫利昔单抗 医学 内科学 胃肠病学 炎症性肠病 阿达木单抗 槽水位 外科 疾病 他克莫司 移植
作者
Benjamin Pariente,Guillaume Pineton de Chambrun,Roman Krzysiek,Marine Desroches,Gauthier Louis,Chiara De Cassan,Clotilde Baudry,Jean–Marc Gornet,Pierre Desreumaux,Dominique Émilie,Jean–Frédéric Colombel,Matthieu Allez
出处
期刊:Inflammatory Bowel Diseases [Oxford University Press]
卷期号:18 (7): 1199-1206 被引量:108
标识
DOI:10.1002/ibd.21839
摘要

Infliximab is effective for the treatment of refractory inflammatory bowel disease (IBD). Nevertheless, up to 40% of patients lose response to infliximab over time. The aim was to assess the clinical value of measuring infliximab trough levels and antibodies to infliximab (ATI) concentrations in IBD patients who lost response to infliximab therapy. We retrospectively studied records of IBD patients who lost response to infliximab therapy. We first assessed clinical responses of different therapeutic strategies that were applied when patients lost response to infliximab and then we looked at the correlation between clinical response and infliximab trough levels and ATI concentrations. Seventy-six IBD patients were included. 31/76 patients (41%) continued infliximab therapy without any modification, 39 patients (51%) had an intensification of infliximab therapy, five patients (7%) had switched to adalimumab therapy, and one patient (1%) underwent surgery. Clinical response was observed in 27 patients (69%) with an intensification of infliximab therapy. There was no significant difference in mean infliximab trough level at inclusion in patients who responded to intensification of infliximab therapy (3.3 ± 4.1 μg/mL) as compared with patients who did not respond (2.3 ± 2.2 μg/mL, P = 0.85). In all, 16/76 patients (22.4%) presented detectable ATI in the serum. Ten ATI-positive patients had an intensification of infliximab therapy and six (60%) demonstrated a clinical response. After intensification of infliximab therapy the ATI concentration decreased in five patients. In patients with IBD who lose response to infliximab, clinical improvement may occur upon intensification of infliximab therapy, irrespective of infliximab serum concentration or presence of ATI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fantasy完成签到,获得积分10
刚刚
好好好完成签到,获得积分10
4秒前
刻苦的小土豆完成签到 ,获得积分10
6秒前
Eva完成签到 ,获得积分10
6秒前
遇上就这样吧完成签到,获得积分0
7秒前
Abiu完成签到,获得积分10
8秒前
11秒前
kytm发布了新的文献求助10
11秒前
张辰熙完成签到 ,获得积分10
11秒前
科研小白完成签到 ,获得积分10
11秒前
疯狂的凡梦完成签到 ,获得积分10
13秒前
爆米花应助cyt9999采纳,获得10
14秒前
友好冥王星完成签到 ,获得积分10
14秒前
linmu完成签到 ,获得积分10
14秒前
18秒前
CodeCraft应助kytm采纳,获得10
19秒前
义气严青完成签到,获得积分10
22秒前
23秒前
大方大船完成签到,获得积分10
24秒前
爱吃煎饼果子的芋圆完成签到 ,获得积分10
24秒前
25秒前
不能随便完成签到,获得积分10
27秒前
qqq完成签到 ,获得积分10
28秒前
30秒前
就看最后一篇完成签到 ,获得积分10
36秒前
我爱Chem完成签到 ,获得积分10
36秒前
没有蛀牙发布了新的文献求助10
36秒前
38秒前
大侦探皮卡丘完成签到,获得积分10
40秒前
卿莞尔完成签到 ,获得积分0
40秒前
Steven发布了新的文献求助10
42秒前
明时完成签到,获得积分10
43秒前
李大刚完成签到 ,获得积分10
46秒前
47秒前
48秒前
Vaibhav完成签到,获得积分10
49秒前
天天快乐应助su采纳,获得10
49秒前
仿生人完成签到,获得积分10
50秒前
义气芷蝶完成签到 ,获得积分10
52秒前
结实凌瑶完成签到 ,获得积分10
53秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3965486
求助须知:如何正确求助?哪些是违规求助? 3510787
关于积分的说明 11155074
捐赠科研通 3245247
什么是DOI,文献DOI怎么找? 1792783
邀请新用户注册赠送积分活动 874096
科研通“疑难数据库(出版商)”最低求助积分说明 804171